Vito J Palombella Selected Research

Neoplasm Metastasis (Metastasis)

1/2023	SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor Properties.
1/2019	Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vito J Palombella Research Topics

Disease

12	Neoplasms (Cancer) 01/2023 - 07/2006
2	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Inflammation (Inflammations) 11/2016
1	Parasitic Diseases (Parasitic Disease) 11/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2014
1	Asthma (Bronchial Asthma) 11/2013
1	Experimental Arthritis 11/2013
1	Hematologic Diseases (Blood Diseases) 11/2013
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2013
1	Medulloblastoma 07/2009
1	Multiple Myeloma 05/2008
1	Autoimmune Diseases (Autoimmune Disease) 02/2008
1	Colonic Neoplasms (Colon Cancer) 11/2006

Drug/Important Bio-Agent (IBA)

5	tanespimycin (17AAG)IBA 12/2010 - 07/2006
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2006
4	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2010 - 07/2006
2	CytokinesIBA 01/2020 - 11/2016
2	EnzymesIBA 01/2019 - 12/2009
2	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2008 - 11/2006
2	marizomibIBA 11/2008 - 11/2006
2	Proteasome InhibitorsIBA 11/2006 - 11/2006
1	Adenosine (Adenocard)FDA LinkGeneric 01/2023
1	Adenosine Triphosphatases (ATPase)IBA 01/2023
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	Chemotactic FactorsIBA 01/2020
1	Chemokine CCL3IBA 01/2020
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2019
1	abirateroneIBA 01/2019
1	enzalutamideIBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	Androgen Receptors (Androgen Receptor)IBA 01/2019
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 11/2016
1	Programmed Cell Death 1 ReceptorIBA 11/2016
1	AntibodiesIBA 11/2016
1	B7-H1 AntigenIBA 11/2016
1	IPI-549IBA 09/2016
1	Drug CombinationsIBA 01/2014
1	Antimitotic AgentsIBA 01/2014
1	OvalbuminIBA 11/2013
1	duvelisibIBA 11/2013
1	Therapeutic UsesIBA 11/2013
1	hydroquinone (Esoterica)FDA Link 12/2009
1	quinone (benzoquinone)IBA 12/2009
1	IPI-926IBA 07/2009
1	cyclopamineIBA 07/2009
1	Immunoglobulin G (IgG)IBA 02/2008
1	NF-kappa B (NF-kB)IBA 11/2006
1	Bortezomib (Velcade)FDA Link 11/2006

Therapy/Procedure

2	Therapeutics 11/2016 - 11/2006
1	Castration 01/2019
1	Immunotherapy 11/2016
1	Aftercare (After-Treatment) 12/2010
1	Oral Administration 07/2009
1	Drug Therapy (Chemotherapy) 11/2006